Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors
Approximately 800,000 strokes occur each year in the United States alone. A majority of people survive, due in part to key advances in patient care over the years, but they often go forward without receiving the long-term help they need to recover and thrive.
Advancing AI for vascular surgery will require a commitment to data integrity
For artificial intelligence to truly transform care, the healthcare industry must address certain challenges. Jens Eldrup-Jorgensen, MD, a veteran vascular surgeon and member of the Society for Vascular Surgery, explains in a guest editorial.
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.
Genetic predisposition to depression increases CVD risk in women, but not men
The heightened risks were even seen in women who were never diagnosed with a psychiatric disorder. It remains unclear why the same trend was not seen in men.
Clopidogrel vs. aspirin: Tracking the chronic maintenance period after PCI for different risk groups
As more high-risk patients undergo PCI, what is the best antiplatelet strategy following an initial event-free period of DAPT? Does it change after complex PCI? Researchers aimed to answer these questions, and many others, with new findings published in JAMA Cardiology.

Fast walking speed associated with reduced mortality risk

Putting some extra pep in your step may prolong your life, according to a study published June 1 in the British Journal of Sports Medicine.

June 4, 2018

Image-guided atherectomy system gains FDA approval

Avinger announced last week the FDA has approved its next-generation Pantheris Lumivascular atherectomy device, which is used to remove plaque from a blood vessel in those with peripheral artery disease (PAD).

June 1, 2018

MicroVention® Announces FDA Approval For Neuro Stent Device

ALISO VIEJO, Calif., May 31, 2018 — MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the LVIS® and LVIS® Jr. stents for stent-assisted coil embolization of intracranial aneurysms.

June 1, 2018

Telerehab for arm motor status shows promise in stroke patients

In-home physical therapy using telehealth systems, supervised by a licensed physical therapist, is effective for stroke rehabilitation, according to a study presented May 24 at the 2018 European Stroke Organization Conference in Gothenburg, Sweden.

May 31, 2018

DOACs can be safely continued during elective procedures on AFib patients

With shorter half-lives and more predictable effects, direct oral anticoagulants (DOACs) could help simplify perioperative treatment decisions for patients with non-valvular atrial fibrillation (NVAF), suggests a meta-analysis published May 24 in Circulation.

May 31, 2018

Severe eczema in adulthood may increase CVD risk by 70%

Severe and active atopic eczema in adulthood is associated with an increased risk for developing cardiovascular disease (CVD), including stroke, heart failure, myocardial infarction (MI) and atrial fibrillation (AFib), according to a new study published May 23 in The BMJ.

May 31, 2018

Growth hormone may help restore cognitive function after stroke

Human growth hormone showed the potential to improve the memory and cognitive function of mice post-stroke, raising the possibility of a similar treatment for humans.

May 30, 2018

Combo of vascular risk, brain amyloid could quicken mental decline

Individuals with a combination of vascular risk factors and higher levels of beta-amyloid protein in the brain may be on a speedier path of cognitive decline, suggests a study published May 21 in JAMA Neurology.

May 25, 2018

Vascular & Endovascular

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors

Advancing AI for vascular surgery will require a commitment to data integrity

Industry concerns over paclitaxel-coated devices may have put PAD patients at risk

Genetic predisposition to depression increases CVD risk in women, but not men

Clopidogrel vs. aspirin: Tracking the chronic maintenance period after PCI for different risk groups